News & Insights
Besides sharing our hands-on expertise in projects, we regularly share industry insights, updates, and news. At NecstGen, we believe in sharing best practices to advance patient health. Together.
News
Stay up to date with the latest news, press releases and events here!
EIC Awards €2.5 Million Grant
Following a rigorous selection process by an expert panel, Trince, NecstGen, and IBSAL are proud to announce that their “Penphomet” project has been selected by The European Innovation Council (EIC) for a significant grant of €2.5 million.
NecstGen and Aarhus University Collaborate in Groundbreaking Initiative for GMP-Compliant Stem Cell Production
NecstGen, Netherlands, a pioneering biotechnology center and non-profit CDMO specialising in Gene and Cell therapy, is proud to announce its groundbreaking collaboration with the Center for Gene and Cellular Therapy at Aarhus University Hospital (AUH), Denmark.
Working at NecstGen: Marten Visser
We spoke with Marten Visser who tells us about working as a Cell Therapy Specialist and how his work helps clients in transitioning to GMP and production.
NecstGen and ProteoNic Report Development of Improved Viral Vectors Through the Application of Premium 2G UNicTM Technology
NecstGen and ProteoNic announce the successful development of improved lentiviral vectors for Cell and Gene Therapy, leveraging ProteoNic’s premium 2G UNic™ technology.
Cline Scientific announces Letter of Intent with NecstGen for the manufacture of its stem cell therapy for damaged cartilage
Cline Scientific announces Letter of Intent with NecstGen for the manufacture of its stem cell therapy for damaged cartilage
bioMérieux partners with NecstGen
bioMérieux and NecstGen, collaborate to accelerate the development of Cell and Gene Therapies (CGT) through the provision of ‘state of the art’ and rapid quality and safety testing technologies that will allow safe and effective advanced therapeutics production.
NecstGen Announces Major Milestone – GMP Manufacturing License
The NecstGen team is happy to announce that is has received its GMP Manufacturing License.
Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development
Pan Cancer T and NecstGen Collaborate to Accelerate Novel TCR-T Therapies into Clinical Development.
Press Release Horizon Europe Grant BioProS
As part of the Horizon Europe framework, NecstGen has joined an international consortium, that will work to develop Biointelligent Sensors for real time in production measurement and control of therapeutics including Cell and Gene Therapies.
Press Release Opening NecstGen
NecstGen announces the opening of its Cell and Gene Therapy Manufacturing and Development facility. On 1 June 2022, NecstGen’s brand-new GMP manufacturing and development facility for cell and gene therapies has been opened by Henri Lenferink (Mayor of Leiden), in the...
NecstGen participates in € 300 million stem cell consortium
Today, the Novo Nordisk Foundation announced the € 300 million funding of an international consortium including Leiden University Medical Center, the Danstem Institute at the University of Copenhagen and the Murdoch Childrens Research Institute in Melbourne to bring...
Strategic collaboration with Cytiva
Today, NecstGen announces the strategic collaboration with Cytiva, a solutions provider in life sciences. Cytiva offers, among others, specialized expertise in industrial manufacturing of Cell and Gene Therapies. Together, NecstGen and Cytiva will share knowledge,...
NecstGen launches its first development lab
We are happy to announce the launch of NecstGen’s first development laboratory at the Leiden Bio Science Park. Here, our scientists and analytical experts have started the first process development projects, supporting our clients to bring cell- and viral vector-based...
Johan Hyllner joins strategic advisory board of NecstGen
NecstGen announces the addition of Johan Hyllner to its strategic advisory board. Johan Hyllner is leading expert in cell therapy and enabling technologies. He is professor of engineering biology at Linköping University, Sweden and head of the Cell Therapy...
NecstGen contracts Kuijpers for the construction of its Cell and Gene Therapy facility
NecstGen announces that the Dutch constructor Kuijpers has obtained the contract for the construction of its Cell- and Gene Therapy facility. Throughout the next year, NecstGen’s facility will be constructed in Mirai House on the largest Life Science and Health hub of...
Webinars
At NecstGen, we are dedicated to driving innovation and knowledge-sharing in the fields of gene and cell therapy. Our webinar series is designed to provide in-depth insights into cutting-edge topics, including CAR T cell therapies and induced pluripotent stem cells (iPSCs), two of the most promising areas in modern medicine.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Stem Cells
Stem cells hold enormous potential for advancing regenerative medicine, with the ability to repair damaged tissues, treat degenerative diseases, and model complex conditions.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Ex Vivo Gene Therapy
Ex vivo gene therapy is one of the most promising areas in the fight against genetic disorders. By modifying cells outside the body and then reintroducing them into the patient, this approach ensures a high degree of control and precision.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
European Landscape For Cell & Gene Therapy companies
At NecstGen, we aim to support industry partnerships and growth. And to enable the next generation of therapies, it is pivotal to have oversight of the gene and therapy landscape to start collaborations and partnerships so we can challenge today’s possibilities and enable the unthinkable, together.
Did you find what you were looking for?
If not, we would be happy to answer any questions you might have regarding our vacancies or life at NecstGen.
